Den mest hyppigt rapporterede behandlingsassocierede alvorlige bivirkning var dehydrering (4%) oplevet af 5 patienter.
The most frequently reported treatment-associated serious adverse reaction (SAR) was dehydration (4%), experienced by 5 patients.